Copyright
©The Author(s) 2025.
World J Gastroenterol. Feb 28, 2025; 31(8): 100069
Published online Feb 28, 2025. doi: 10.3748/wjg.v31.i8.100069
Published online Feb 28, 2025. doi: 10.3748/wjg.v31.i8.100069
Figure 2 Glial cell line-derived neurotrophic factor protects against colonic histopathological damage and reduces inflammation in dextran sodium sulfate-induced ulcerative colitis mice.
A: Representative colon tissue sections stained by hematoxylin and eosin staining showing histopathological changes in each group (scale bar: 100 μm); B: Histological scores; Quantification of serum levels of C: C-reactive protein; D: Tumor necrosis factor-α; E: Interleukin-1β; F: Interleukin-6 using enzyme-linked immunosorbent assay. Data were presented as mean ± SD (n = 8). aP < 0.05. bP < 0.01. GDNF: Glial cell line-derived neurotrophic factor; UC: Ulcerative colitis; CN: Normal control; CRP: C-reactive protein; TNF-α: Tumor necrosis factor-α; IL: Interleukin.
- Citation: Yang W, Liu R, Xu F. Glial cell line-derived neurotrophic factor improves impaired colonic motility in experimental colitis mice through connexin 43. World J Gastroenterol 2025; 31(8): 100069
- URL: https://www.wjgnet.com/1007-9327/full/v31/i8/100069.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i8.100069